UnitedHealthcare
Sympazan (clobazam)
Drugs for the Nervous System : Drugs for Seizures /Personality Disorder/Nerve Pain
  • Step Therapy: Neurology: Epilepsy:
    ST Single Generic

  • Lennox Gastaut Syndrome (LGS):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

    Neurology: Epilepsy:
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified
    Diagnosis Type(s): 1 of Partial-Onset Seizures;Seizures Associated with Lennox-Gastaut Syndrome (LGS)
    Used as Adjunctive Treatment: No
    Duration of Failure or Adjunctive Treatment with Other Antiepileptic Product: N/A
    Documented history of persisting seizures after titration to highest tolerated dose of each AED.: No
    Lack of compliance as a reason for treatment failure has been ruled out: No
    Documentation of treatment failure due to intolerable side effects.: No
    Supporting Documentation Requirements: Chart Notes
    Positive Response to Therapy Required for Reauth: Yes
    Treatment for Age 17 years or older: No
    Treatment for Age 1-16 years old: No
    History of >= to 30 day trial of other AED required: No
    Reapproval based on response: Yes

  • Prior Authorization: Lennox Gastaut Syndrome (LGS):
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Neurology: Epilepsy:
    Documented Diagnosis: Yes
    Reauthorization Required: Yes